GovChime
AWARDPURCHASE ORDEROther than small business

Purchase order 75N91023P00216WEIZMANN INSTITUTE OF SCIENCE

Overview

Award facts

Net obligations
$12K
$12,000of $12K potential value
Period of performance
Feb 1, 2023 to Jan 31, 2024
Ended
Modifications
0
Latest action Jan 20, 2023
Contract type
Purchase order
PIID 75N91023P00216

Description of requirement

SUPPORT ASSAYING OF DNA SAMPLES FROM THE BENZENE BIOMARKER STUDY

Dates and value

Award date
Signed on Jan 20, 2023
Potential end of performance
Jan 30, 2024
Current value
$12,000Base and exercised options
Potential value (if all options are exercised)
$12,000

Obligations by fiscal year of action

  • FY2023: $12,000

Total across 1 fiscal year: $12,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 20, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationREHOVOT, ISR
UEINPJ8YBLFTKX6
CAGE code2846A
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationEducational institutionLimited liability companyTax-exempt corporation

Self-reported at the time of the action.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Israel

Classification and competition

Classification

Product or service (PSC)
Q301MEDICAL- LABORATORY TESTING (service)

Competition

Extent competed
Competed under SAPF
Solicitation procedures
Simplified acquisitionSP1
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Jan 20, 2023Base obligation at award: $12,000
Latest action
Jan 20, 2023 — Base awardModification 0; obligation change +$12,000
Actions by type
  • Base award1
1 actions recorded, Jan 20, 2023 to Jan 20, 2023; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$12,000
Latest action: change in base and all options
$12,000

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Other foreign entity (e.g. foreign government)O
Country of product or service origin
IsraelISR
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
1

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2023/2023-0849-000
Object classes
  • 25.6: Medical care
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression